• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

he-lp2

HE Undergraduates in nanotechnology (EQF 6):

HE-LP2SARS-CoV-2 detection and COVID-19 diagnosis
SummaryThe mechanisms affecting viral properties and approaches aimed at utilizing viral particle characteristics are presented in this training unit. It also provides information about nanomaterials as excellent candidates against CoVs infections because of their particular features that allow instant, accurate, and quick detection of the contagious agents and their exact and fast treatment. The advances of nanotechnology in offering specific, sensitive, and rapid diagnostic tools to detect the infection at an early stage of its development are described. This training unit presents data about the global problem related to the lack of formal regulation of nanomedicines and the manufacture of nanomaterials for health-related applications. Emphasis is given on the need an international nanomaterials regulation consortium to be formed to issue recognized guidance to the research communities.
ULOs
Knowledge & Skills		Upon completion of HE-LP2 the trainee will be able to:
  • Explain the need for personal protective equipment due to the spread of SARS-CoV 2;
  • Know about the presence and persistence of SARS-CoV 2 on different inanimate surfaces;
  • Understand the contribution of nanotechnology in the global fight against new coronavirus disease;
  • Distinguish the main categories of Nanotechnology-enabled Personal Protective Equipment (PPE);
  • Reveal the safety of nano-based PPE product
  • Describe the current methods of detection of SARS-CoV-2;
  • Define the properties and categories of nanomaterials for SARS-CoV-2 detection;
  • Understand the differences between nanomaterials;
  • Demonstrate the main challenges and limitations of nanomaterials;
  • Discuss the application of nanomaterials for SARS-CoV-2 detection.
  • List the current laboratory methods for diagnosis of SARS-CoV-2;
  • Understand the categories of nanotechnology (nano biosensors, point-of-care testing and nanopore target sequencing);
  • Identify the differences between nano biosensors;
  • Illustrate the main challenges and limitations of nanotechnology in COVID-19;
  • Discuss the application of nanotechnology for diagnosis of SARS-CoV-2.
  • develop the problem-solving skills to describe the most important tasks of legislation with regard to the application of new technologies using the example of nanotechnology in the field of molecular genetics-based vaccine development,
  • assess personal aspects by discussing the safety risks for health and the environment and the possible risks in the context precisely because of the lack of specific regulatory guidelines for many nanomedicines that are on the market and whose number is constantly increasing,
  • understand the basic concerns of technology-related bio-law in terms of technology assessment, because these are used mainly in cancer therapy, as they require toxic compounds, which hinders effective drug treatment,
  • recognise the lack of formal regulation of nanomedicines and the production of nanomaterials for health-related applications as a global problem, in order to better assess the future development of technology and society
CompositionLO 1.1. Viral particles and functional nanomaterials crossing point
LO 3.1. Nanomaterials in design and application of SARS-CoV-2 detection methods
LO 3.2. Nanotechnology in diagnostic techniques for SARS-CoV-2
LO 6.2. Law and nanoscience interface: legal doctrines relevant to nanotechnology
(Self)AssessmentHE-LP2 Test
Credit points6
ValidationCertificate
This project has been funded with support from the European Commission. This web-site reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein.